Literature DB >> 35527500

[Preparation of purified proteins from fresh Pheretima and their inhibitory effect against pulmonary fibrosis in mice].

S Li1, Q Yang1, A Zuo1, L Tian2, J Huo2, Y Meng2, Q Tang1, W Wang1,2.   

Abstract

OBJECTIVE: To develop a convenient method for rapid purification of fresh Pheretima proteins and assess the inhibitory effect of these proteins against pulmonary fibrosis.
METHODS: The crude extract of fresh Pheretima was obtained by freeze-drying method and then purified by size exclusion chromatography. The composition of the purified proteins was analyzed by mass spectrometry. MRC-5 cells were treated with 5 ng/mL TGF-β1 alone (model group) or in combination with SB431542 (2 μmol/L) or the purified proteins (13.125 μg/mL), and the cytotoxicity of purified proteins and their inhibitory effects on cell proliferation were detected with CCK8 assay. Flow cytometry was used to detect the changes in cell apoptosis, and the cellular expressions of α-SMA, Vimentin, E-cadherin, collagen I, Smad2/3 and P-Smad2/3 were detected using RT-PCR and Western blotting. In the animal experiment, adult male C57BL/6 mice were subjected to intratracheal instillation of bleomycin followed by treatment with the purified proteins (5 mg/mL) for 21 days, after which HE and Masson staining was used to observe the pathological changes in the lung tissue of the mice.
RESULTS: We successfully obtained purified proteins from fresh Pheretima protein by size exclusion chromatography. Treatment with the purified proteins significantly inhibited TGF-β1-induced proliferation of MRC-5 cells (P < 0.01), reduced the cellular expressions of α-SMA, Vimentin and collagen I (P < 0.001 or P < 0.01), increased the expression of E-cadherin (P < 0.01), and inhibited the expressions of Smad2/3 and P-Smad2/3 (P < 0.001 or P < 0.01). In male C57BL/6 mice models of bleomycin-induced pulmonary fibrosis, treatment with the purified proteins obviously reduced the number of inflammatory cells and fibrotic area in the lungs.
CONCLUSION: The purified proteins from fresh Pheretima obtained by size exclusion chromatography can inhibit pulmonary fibrosis in mice by regulating the TGF-β/ Smad pathway.

Entities:  

Keywords:  fresh Pheretima; mass spectrometry; myofibroblasts; protein purification; transforming growth factor -β1

Mesh:

Substances:

Year:  2022        PMID: 35527500      PMCID: PMC9085584          DOI: 10.12122/j.issn.1673-4254.2022.04.20

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  15 in total

1.  miR-770-5p inhibits the activation of pulmonary fibroblasts and silica-induced pulmonary fibrosis through targeting TGFBR1.

Authors:  Jiali Yuan; Ping Li; Honghong Pan; Qi Xu; Tiantian Xu; Yan Li; Dong Wei; Yiqun Mo; Qunwei Zhang; Jingyu Chen; Chunhui Ni
Journal:  Ecotoxicol Environ Saf       Date:  2021-05-31       Impact factor: 6.291

2.  Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.

Authors:  Silvio Danese; Filippo Mocciaro; Luisa Guidi; Maria Lia Scribano; Michele Comberlato; Vito Annese; Elisabetta Colombo; Tommaso Stefanelli; Manuela Marzo; Marcello Vangeli; Raffaella Pulitano'; Aldo Manca; Alessandro Armuzzi; Alberto Malesci; Cosimo Prantera; Mario Cottone
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

3.  [Pulmonary artery sarcoma that simulates pulmonary thromboembolism].

Authors:  Agustín M Serra; María Mercedes Kleinert; Osvaldo Tenorio Núñez; Ignacio Nogués; Bárbara Hunter; Javier D Osatnik
Journal:  Medicina (B Aires)       Date:  2019       Impact factor: 0.653

4.  Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.

Authors:  Eun Hye Lee; Kwang-Il Park; Kwang-Youn Kim; Ju-Hee Lee; Eun Jeong Jang; Sae Kwang Ku; Sang Chan Kim; Ho Young Suk; Ji Young Park; Su Youn Baek; Young Woo Kim
Journal:  Phytomedicine       Date:  2018-12-10       Impact factor: 5.340

Review 5.  Idiopathic Pulmonary Fibrosis.

Authors:  David J Lederer; Fernando J Martinez
Journal:  N Engl J Med       Date:  2018-05-10       Impact factor: 91.245

6.  Effects of Traditional Chinese Medicine, Dilong Injection, on Random Skin Flap Survival in Rats.

Authors:  Lina Xu; Dingsheng Lin; Bin Cao; Dongnan Ping
Journal:  J Invest Surg       Date:  2017-01-20       Impact factor: 2.533

7.  Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.

Authors:  Yan-Zhi Xia; Guo-Fa Shan; Hua Yang; Jun Zha; Li Wang; Jie-Mei Chen; Xue-Song Zhang
Journal:  Chem Biol Interact       Date:  2021-02-19       Impact factor: 5.192

8.  L-carnitine suppresses transient receptor potential vanilloid type 1 activity and myofibroblast transdifferentiation in human corneal keratocytes.

Authors:  Elizabeth Turan; Monika Valtink; Peter S Reinach; Annett Skupin; Huan Luo; Tobias Brockmann; Marah Hussain Omar Ba Salem; Uwe Pleyer; Stefan Mergler
Journal:  Lab Invest       Date:  2021-02-26       Impact factor: 5.662

9.  Anti-Asthma Effect of an Active Components Group from Decoction of Pheretima Aspergillum and Its Chemical Composition Characterized by Liquid Chromatography-Quadrupole Time of Flight Mass Spectrometry.

Authors:  Qingxin Shi; Xuanyuan Wang; Junyi Liu; Xingliang Xiang; Mingwu Su; Rongzeng Huang; Chengwu Song
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

10.  Dyspnoea with progressive "idiopathic" pulmonary fibrosis.

Authors:  Chahat Puri; Vignesh Harish; Kyunghoon Rhee; Donald F Slack
Journal:  Respirol Case Rep       Date:  2021-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.